In summary, PLAUR, BDKRB2, ADAMTS14, FOSL1, and TIMP1 have all been shown to be involved in the occurrence and development of GBM or related diseases and have the potential to be further developed as prognostic biomarkers. This evidence concerns the gene BDKRB2 and glioblastoma.